These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12041770)

  • 1. Efficacy of teicoplanin and imipenem on respiratory infections in high risk patients.
    Piu G; Aresu G; Pautasso M; Garau G; Melis S; Ceccio S; Morini M; Palomba A
    J Chemother; 1991 Jan; 3 Suppl 1():222-3. PubMed ID: 12041770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Are we being threatened by multiresistant strains of Staphylococcus aureus?].
    Aepfelbacher M
    MMW Fortschr Med; 2005 Jan; 147(4):33-5, 37. PubMed ID: 15745339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections.
    Baran G; Erbay A; Bodur H; Ongürü P; Akinci E; Balaban N; Cevik MA
    Int J Infect Dis; 2008 Jan; 12(1):16-21. PubMed ID: 17513154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meropenem and imipenem activity against Pseudomonas aeruginosa isolates from the MYSTIC Program.
    Turner PJ
    Diagn Microbiol Infect Dis; 2006 Nov; 56(3):341-4. PubMed ID: 17049798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
    Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
    Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospital acquired native valve endocarditis caused by Acinetobacter calcoaceticus and treated with imipenem/cilastin.
    Cumberland NS; Jones KP
    J R Army Med Corps; 1987 Oct; 133(3):156-8. PubMed ID: 3479562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of meropenem and comparators against Pseudomonas aeruginosa and Acinetobacter spp. isolated in the MYSTIC Program, 2002-2004.
    Unal S; Garcia-Rodriguez JA
    Diagn Microbiol Infect Dis; 2005 Dec; 53(4):265-71. PubMed ID: 16360550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of the Acinetobacter calcoaceticus-A. baumannii complex to imipenem, meropenem, sulbactam and colistin.
    Dueñas Díez AI; Bratos Pérez MA; Eiros Bouza JM; Almaraz Gómez A; Gutiérrez Rodríguez P; Miguel Gómez MA; Orduña Domingo A; Rodríguez-Torres A
    Int J Antimicrob Agents; 2004 May; 23(5):487-93. PubMed ID: 15120728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nosocomial methicillin-resistant staphylococci that remain sensitive to non-beta lactam antibiotics].
    Manfredi R; Nanetti A; Morelli S; Valentini R; Ferri M; Calza L; Chiodo F
    Recenti Prog Med; 2003; 94(7-8):344. PubMed ID: 12868245
    [No Abstract]   [Full Text] [Related]  

  • 10. Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections.
    Saballs M; Pujol M; Tubau F; Peña C; Montero A; Domínguez MA; Gudiol F; Ariza J
    J Antimicrob Chemother; 2006 Sep; 58(3):697-700. PubMed ID: 16895941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative in vivo efficacy of meropenem, imipenem, and cefepime against Pseudomonas aeruginosa expressing MexA-MexB-OprM efflux pumps.
    Ong CT; Tessier PR; Li C; Nightingale CH; Nicolau DP
    Diagn Microbiol Infect Dis; 2007 Feb; 57(2):153-61. PubMed ID: 16930925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and clinical outcomes of nosocomial multi-drug resistant Pseudomonas aeruginosa infections.
    Cao B; Wang H; Sun H; Zhu Y; Chen M
    J Hosp Infect; 2004 Jun; 57(2):112-8. PubMed ID: 15183240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro effect of antibiotics against hospital strains of Acinetobacter baumanii].
    Hercouet H; Bousser J; Donnio PY; Avril JL
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):612-6. PubMed ID: 2797884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An outbreak of imipenem-resistant Acinetobacter baumannii at Songklanagarind Hospital: the risk factors and patient prognosis.
    Jamulitrat S; Thongpiyapoom S; Suwalak N
    J Med Assoc Thai; 2007 Oct; 90(10):2181-91. PubMed ID: 18041440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimising antibiotic dosing regimens based on pharmacodynamic target attainment against Pseudomonas aeruginosa collected in Hungarian hospitals.
    Ludwig E; Konkoly-Thege M; Kuti JL; Nicolau DP
    Int J Antimicrob Agents; 2006 Nov; 28(5):433-8. PubMed ID: 17046212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal Acinetobacter baumannii infection with discordant carbapenem susceptibility.
    Lesho E; Wortmann G; Moran K; Craft D
    Clin Infect Dis; 2005 Sep; 41(5):758-9. PubMed ID: 16080102
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of superinhibitory levels of imipenem and amikacin singly or in combination on Pseudomonas aeruginosa].
    Hostacká A
    Epidemiol Mikrobiol Imunol; 1997 Dec; 46(4):155-7. PubMed ID: 9471306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model.
    Song JY; Cheong HJ; Lee J; Sung AK; Kim WJ
    Int J Antimicrob Agents; 2009 Jan; 33(1):33-9. PubMed ID: 18835761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Teicoplanin resistance in methicillin-resistant Staphylococcus aureus in an intensive care unit.
    Cepeda J; Hayman S; Whitehouse T; Kibbler CC; Livermore D; Singer M; Wilson AP
    J Antimicrob Chemother; 2003 Sep; 52(3):533-4. PubMed ID: 12888581
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuroinfections and antimicrobials: do we need new molecules or new strategies?
    Kalavsky E; Kisac P; Huttova M; Benca J; Krcmery V
    Neuro Endocrinol Lett; 2007 Jun; 28 Suppl 2():38-9. PubMed ID: 17558378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.